Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$978,712
+$122,054 QoQ
Shares Held
260,990
-8.3% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. ACRS ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $978,712 260,990
2025-12-31 $856,658 284,604
2025-09-30 $459,716 241,956
2025-06-30 $371,043 261,298
2025-03-31 $50,610 33,079
2024-12-31 $82,035 33,079
2024-06-30 $286,776 260,706
2024-03-31 $519,974 419,334
2023-12-31 $458,146 436,330
2023-09-30 $3,173,152 463,234
2023-06-30 $4,606,986 444,261
2023-03-31 $3,318,679 410,220
2022-12-31 $6,491,094 412,133
2022-09-30 $6,336,199 402,554
2022-06-30 $2,154,293 154,319
2022-03-31 $2,294,092 133,068
2021-12-31 $1,874,395 128,913
2021-09-30 $2,284,488 126,916
2021-06-30 $1,893,635 107,838
2021-03-31 $397,882 15,789
2020-12-31 $132,667 20,505
2020-09-30 $52,697 20,505
2020-06-30 $33,218 20,505
2020-03-31 $88,090 84,702